Dexcom, Inc. is an American multinational healthcare company that develops, manufactures, and distributes continuous glucose monitoring (CGM) systems for diabetes management. Headquartered in San Diego, California, the company has pioneered and set the standard in glucose biosensing for over 25 years. Its product portfolio includes the Dexcom G7 CGM systems and the Stelo glucose biosensor, designed to help people manage diabetes and track glucose in real time. Dexcom is a public company listed on Nasdaq (DXCM), is a component of the S&P 500 and Nasdaq-100 indices, and operates manufacturing facilities in the United States, Malaysia, and Ireland with approximately 11,100 employees.
| Import | Export |
|---|---|
|
Trade Records
1291
|
Trade Records
71
|
|
Suppliers
13
|
Buyers
4
|
|
Latest Import Date
2026-07
|
Latest Export Date
2026-03
|
According to Topease's global trade data, DEXCOM INC exports products to verified importers across global markets.
Its export activity is associated with HS-code categories such as:
Representative importers include:
These export insights help users understand the DEXCOM INC distribution footprint, product specialization, and shipment scale. Through Topease's deep trade data and trade intelligence capabilities—such as trade flow analysis and market benchmarking—importers and exporters can evaluate downstream demand and identify potential importer relationships.
As an importer, DEXCOM INC sources products from verified exporters across multiple regions.
Its import activity spans HS-code categories including:
Representative exporters include:
These import insights help users assess sourcing patterns, supplier concentration, and trade continuity. With Topease's analytical tools—such as sourcing pattern analysis and supply-chain mapping—users can evaluate supplier performance and identify diversification opportunities.
Explore DEXCOM INC's import activity, including trade volumes, top suppliers, sourcing countries, and key product categories. These insights allow exporters and potential suppliers to understand its global supply chains, track procurement trends, and identify new business opportunities.
| Exporter | Importer | HS Code | Number of Trade | Amount (USD) | Quantity | Import Port |
|---|---|---|---|---|---|---|
| DEXCOM M SDN BHD | DEXCOM INC | 3919 | 24 | $186,500 | 3,420 | Los Angeles |
| WORLDMARK DE MEXICO S. R.L. DE C.V. | DEXCOM INC | 3919 | 24 | $186,500 | 3,420 | Los Angeles |
| JABIL CIRCUIT DE CHIHUAHUA S. R.L. DE C.V. | DEXCOM INC | 4901 | 24 | $186,500 | 3,420 | Los Angeles |
| PT. SURYA TEKNOLOGI BATAM | DEXCOM INC | 8471 | 24 | $186,500 | 3,420 | Los Angeles |
| DEXCOM MALAYSIA M SDN BHD | DEXCOM INC | 3905 | 24 | $186,500 | 3,420 | Los Angeles |
Gain insights into DEXCOM INC's export activities, including shipment volumes, key buyers, destination countries, and product categories. Understand global demand patterns, track sales reach, and spot opportunities to connect with potential buyers.
| Importer | Exporter | HS Code | Number of Trade | Amount (USD) | Quantity | Export Port |
|---|---|---|---|---|---|---|
| DEXCOM M SDN BHD | DEXCOM INC | 2835 | 24 | $186,500 | 3,420 | Los Angeles |
| GREEN POINT PRECISION (M) SDN BHD | DEXCOM INC | 8534 | 24 | $186,500 | 3,420 | Los Angeles |
| PENTAMASTER EQUIPMENT MANUFACTURING SDN BHD | DEXCOM INC | 8506 | 24 | $186,500 | 3,420 | Los Angeles |
| DSVA AIR SEA SDN BHD | DEXCOM INC | 8517 | 24 | $186,500 | 3,420 | Los Angeles |
Chain Insights — Explore DEXCOM INC's trading network to uncover connections with international buyers and suppliers. With Topease's Supply Chain Solution, you can track product flows and identify patterns that reveal new sourcing and partnership opportunities.
Access DEXCOM INC's key professional contacts for B2B outreach purposes. View verified phone numbers, emails, and LinkedIn profiles to facilitate efficient business communication.
Disclaimer: Data is compiled from public and third-party sources and may not be complete or fully accurate. This information is provided for business intelligence purposes only and should not be used for legal, financial, or compliance decisions.